{"id":51146,"date":"2022-11-22T18:02:59","date_gmt":"2022-11-22T17:02:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/clinical-trial-investigative-site-network-global-market-report-2022-increasing-partnership-amongst-contract-research-sites-boosting-growth-researchandmarkets-com\/"},"modified":"2022-11-22T18:02:59","modified_gmt":"2022-11-22T17:02:59","slug":"clinical-trial-investigative-site-network-global-market-report-2022-increasing-partnership-amongst-contract-research-sites-boosting-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/clinical-trial-investigative-site-network-global-market-report-2022-increasing-partnership-amongst-contract-research-sites-boosting-growth-researchandmarkets-com\/","title":{"rendered":"Clinical Trial Investigative Site Network Global Market Report 2022: Increasing Partnership Amongst Contract Research Sites Boosting Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Investigative Site Network Market Size, Share & Trends Analysis Report by Therapeutic Areas (Oncology, CNS), by Phase (Phase I, III), by End-use (Sponsor, CRO), by Region, and Segment Forecasts, 2022-2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global clinical trial investigative site network market size is expected to reach USD 12.5 billion by 2030, registering a CAGR of 6.0% over the forecast period. Growing investments in pharmaceutical R&D, increasing demand for new therapies and complications associated with site management of clinical trials are some of the major factors driving the growth of the industry. There has been a consistent rise the clinical trials in the last 5 years. For instance, according to ClinicalTrials.gov, over 262,298 trials were registered in 2018, whereas as of September 2022, over 399,518 trials were registered. The clinical trials are expected to grow even further as the funding for research improves.\n<\/p>\n

\nThis is expected to propel the growth of the industry post-pandemic. There is a growing focus on reducing the cost associated with clinical research. Hiring a clinical trial investigative site network supports the regulatory function, improves the enrollment of participants, assists in data management, and quality assurance. It increases process compliance, reduces process issues with each trial, and helps with faster trial initiations, and shorter trial timelines. These factors are supporting the demand for clinical investigative site networks. The governments are actively trying to improve R&D by providing tax deductions. For instance, in January 2022, the Indian government stated that it is providing a weighted average tax deduction of up to 200% in R&D.\n<\/p>\n

\nSuch initiatives are expected to improve the R&D activities on drugs and thus support industry growth. According to the IQVIA, report on oncology trends, clinical trials for cancer have been increasing for the last 10 years. For instance, in 2011, 1,242 trials were registered for cancer, and as of 2021, 2,335 trials were registered for cancer. The number of clinical trials for cancer is expected to rise even further owing to the growing prevalence of the disease. This is expected to improve the demand for clinical investigative site networks for cancer clinical trials post-pandemic.\n<\/p>\n

\nClinical Trial Investigative Site Network Market Report Highlights<\/strong>\n<\/p>\n